informační dopis – Ventolin Inhaler N

The State Institute for Drug Control (ŠÚKL) has issued an information letter regarding the medication Ventolin Inhaler N. The letter was published on June 24, 2026, by the Department of Pharmacovigilance. It warns about the risk of possible ineffectiveness of this inhaler. The main reason is the unclear number of remaining doses in the device. This situation may result in patients not receiving the necessary dose of the medication. It is important for patients and healthcare professionals to be informed about this potential issue. For more detailed information, the DHPCVentolin Inhaler N document is available in PDF format (284 kB).